Shruthi Sriram

Shruthi Sriram has a diverse background in the field of clinical laboratory science. Shruthi is currently working at Genome Insight Inc. as a Clinical Laboratory Supervisor, beginning in June 2023. Prior to this role, they were a Clinical Laboratory Scientist at AltheaDx from September 2021 to December 2022, where they performed testing and analysis for pharmacogenomic assays, as well as assay improvements for capillary electrophoresis.

Before joining AltheaDx, Shruthi worked at Sequenom Laboratories from August 2020 to September 2021 as a Technical Clinical Laboratory Scientist. During this time, they performed various NGS NIPS assays and COVID-19 detection testing. Shruthi also played a key role in the development and launch of a COVID-19 variant sequencing assay in collaboration with the CDC. Additionally, they gained experience as a CGMBS Trainee in the Sequenom CGMBS training program from September 2019 to August 2020, where they received their CGMBS license and Technologist in Molecular Biology certification. Prior to that, they worked as a Technical Group Laboratory Associate from April 2017 to September 2019 and as a Specimen Processing Technician from June 2016 to April 2017.

Overall, Shruthi Sriram has demonstrated expertise and proficiency in clinical laboratory science, particularly in the areas of pharmacogenomics, NGS NIPS assays, and COVID-19 testing.

Shruthi Sriram completed their undergraduate education from UC San Diego, where they obtained a Bachelor's degree in Biochemistry and Cell Biology, with a minor in Science, Technology, and Society. Shruthi studied at UC San Diego from 2012 to 2016.

In 2023, Shruthi Sriram enrolled at San Diego Mesa College to pursue a degree in Computer Programming, which is expected to be completed by 2024.

In addition to their educational qualifications, Shruthi Sriram has obtained additional certifications. In August 2020, they earned the certification of Clinical Genetic Molecular Biologist Scientist from the California Department of Public Health. Shruthi also holds the certification of Technologist in Molecular Biology (MB) from the American Society for Clinical Pathology (ASCP), which they obtained in August 2020.